The glycinergic system in human startle disease: a genetic screening approach.
Human startle disease, also known as hyperekplexia (OMIM 149400), is a paroxysmal neurological disorder caused by defects in glycinergic neurotransmission. Hyperekplexia is characterised by an exaggerated startle reflex in response to tactile or acoustic stimuli which first presents as neonatal hypertonia, followed in some with episodes of life-threatening infantile apnoea. Genetic screening studies have demonstrated that hyperekplexia is genetically heterogeneous with several missense and nonsense mutations in the postsynaptic glycine receptor (GlyR) alpha1 subunit gene (GLRA1) as the primary cause. More recently, missense, nonsense and frameshift mutations have also been identified in the glycine transporter GlyT2 gene, SLC6A5, demonstrating a presynaptic component to this disease. Further mutations, albeit rare, have been identified in the genes encoding the GlyR beta subunit (GLRB), collybistin (ARHGEF9) and gephyrin (GPHN) - all of which are postsynaptic proteins involved in orchestrating glycinergic neurotransmission. In this review, we describe the clinical ascertainment aspects, phenotypic considerations and the downstream molecular genetic tools utilised to analyse both presynaptic and postsynaptic components of this heterogeneous human neurological disorder. Moreover, we will describe how the ancient startle response is the preserve of glycinergic neurotransmission and how animal models and human hyperekplexia patients have provided synergistic evidence that implicates this inhibitory system in the control of startle reflexes.
Davies
Jeff S
JS
Institute of Life Science, School of Medicine, Swansea University Singleton Park, Swansea, UK.
Chung
Seo-Kyung
SK
Thomas
Rhys H
RH
Robinson
Angela
A
Hammond
Carrie L
CL
Mullins
Jonathan G L
JG
Carta
Eloisa
E
Pearce
Brian R
BR
Harvey
Kirsten
K
Harvey
Robert J
RJ
Rees
Mark I
MI
Lancet. 1989 Jan 28;1(8631):216
2563117
Am J Hum Genet. 2007 May;80(5):971-81
17436252
Hum Mutat. 2006 Nov;27(11):1160
17041877
Front Mol Neurosci. 2008 Mar 28;1:1
18946534
Mol Cell Neurosci. 2004 Aug;26(4):518-29
15276154
J Neurosci. 1998 Dec 1;18(23):9733-50
9822734
Postgrad Med J. 2001 Sep;77(911):570-2
11524514
Nat Biotechnol. 2008 Oct;26(10):1117-24
18846085
Nat Neurosci. 2005 Jun;8(6):736-44
15895087
J Neurochem. 2004 Sep;90(6):1445-52
15341528
J Child Neurol. 2004 Jul;19(7):522-5
15526957
Trends Biochem Sci. 2005 Jun;30(6):325-33
15950877
J Biol Chem. 2009 Dec 11;284(50):35073-8
19843525
J Biol Chem. 2003 Jul 4;278(27):24688-96
12684523
Neuron. 1994 Oct;13(4):1003-15
7946325
Biochem Biophys Res Commun. 2006 Sep 22;348(2):400-5
16884688
Neuropharmacology. 2009 Jan;56(1):303-9
18721822
Paediatr Anaesth. 2007 Nov;17(11):1099-101
17897277
Am J Hum Genet. 2001 Jan;68(1):208-13
11095995
Nature. 2008 Apr 17;452(7189):872-6
18421352
Nat Genet. 2006 Jul;38(7):801-6
16751771
Nucleic Acids Res. 2007 Jan;35(Database issue):D5-12
17170002
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8345-50
15928085
Eur J Neurosci. 2009 Sep;30(6):1077-91
19723286
Brain. 1980 Dec;103(4):985-97
6777025
Nature. 2005 Sep 8;437(7056):215-23
16041361
J Neurosci. 2004 Jun 23;24(25):5816-26
15215304
Hum Mutat. 2009 Jan;30(1):61-8
18615734
Front Mol Neurosci. 2010 Jan 08;2:26
20161699
Hum Genet. 2001 Sep;109(3):267-70
11702206
Neuron. 2003 Nov 13;40(4):785-96
14622582
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4293-8
12634427
Hum Mol Genet. 2002 Apr 1;11(7):853-60
11929858
Arch Neurol. 1983 Apr;40(4):246-8
6830476
Arch Pediatr Adolesc Med. 1994 May;148(5):540-3
8180653
J Mol Biol. 2000 Sep 8;302(1):205-17
10964570
Neuron. 2003 Nov 13;40(4):797-806
14622583
J Neurosci. 2007 Jun 6;27(23):6273-81
17554001
Bioinformatics. 2007 Mar 15;23(6):769-70
17237072
Clin Chem. 2007 Feb;53(2):349-52
17200131
Mol Pharmacol. 2008 Dec;74(6):1521-32
18768736
Lancet Neurol. 2006 Jun;5(6):513-24
16713923
Trends Genet. 2008 Sep;24(9):439-47
18707791
Front Neurol Neurosci. 2009;26:147-165
19349711
Nat Genet. 1994 Jun;7(2):131-5
7920629
J Child Neurol. 2007 Jul;22(7):895-900
17715287
Mol Cell Neurosci. 2007 Nov;36(3):369-80
17851090
Nucleic Acids Res. 2003 Jul 1;31(13):3375-80
12824331
J Nerv Ment Dis. 1994 Jun;182(6):331-8; discussion 339-41
8201305
Neurophysiol Clin. 2006 Sep-Dec;36(5-6):357-64
17336782
Nat Genet. 1993 Dec;5(4):351-8
8298642
Lancet. 1995 Feb 18;345(8947):461
7853985
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6712-7
19342489
J Neurochem. 2005 Jul;94(2):307-15
15998282
Hum Mol Genet. 1994 Nov;3(11):2025-30
7874121
Am J Med Genet. 1996 Apr 24;62(4):365-71
8723066
Ann Neurol. 1995 Jul;38(1):85-91
7611730
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8485-90
15159536
Neurology. 2008 Oct 14;71(16):1291-2
18852446
Nat Genet. 1994 Jun;7(2):136-41
7920630
Neuron. 2005 Mar 3;45(5):727-39
15748848
Neuron. 2000 May;26(2):307-12
10839351
J Med Genet. 2008 Feb;45(2):100-5
17893116
Hum Mol Genet. 1994 Dec;3(12):2175-9
7881416
FEBS Lett. 1993 Jan 4;315(2):114-8
8093354
J Mol Biol. 1990 Oct 5;215(3):403-10
2231712
Neurology. 2007 Aug 7;69(6):586-95
17679678
Biochem Biophys Res Commun. 2004 May 7;317(3):857-64
15081419
J Pediatr. 1960 May;56:655-7
13819848
Neuron. 1992 Feb;8(2):283-9
1371219
Neurosci Lett. 1998 Feb 6;242(1):25-8
9509996
Acta Psychiatr Neurol Scand. 1958;33(4):471-6
13594585
Development. 1996 Dec;123:399-413
9007258